| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 823-832, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Parronchi, P Romagnani, F Annunziato, S Sampognaro, A Becchio, L Giannarini, E Maggi, C Pupilli, F Tonelli and S Romagnani
Institute of Internal Medicine and Immunoallergology, University of Florence, Italy.
Crohn's disease (CD) is a chronic bowel inflammatory disorder in which the pathogenic role of immune alterations has been suggested, but the immunologic mechanisms responsible for the inflammatory reaction are still poorly understood. We investigated the profile of cytokine secretion by T-cell clones generated from gut tissue specimens of four patients with active CD, five patients with ulcerative colitis, and four patients with noninflammatory gut disorders (NIGDs). The great majority of CD4+ T-cell clones generated from the gut of patients with CD produced high levels of interferon-gamma (IFN-gamma) but low or undetectable amounts of interleukin-4 (IL-4), whereas substantial proportions of CD4+ T-cell clones derived from the gut of patients with either ulcerative colitis or NIGDs produced IL-4 in addition to IFN- gamma. The immunohistochemical analysis revealed high numbers of activated CD4+ T cells showing IFN-gamma but not IL-4 reactivity, as well as substantial proportions of IL-12-containing macrophages, in the intestinal lamina propria and muscularis propria of patients with CD, whereas these cells were very rare or undetectable in patients with NIGDs. Culturing T cells from gut biopsy specimens of a patient with CD in the presence of a neutralizing anti-IL-12 antibody down-regulated the development of IFN-gamma-producing CD4+ T cells. These findings suggest that a critical event in the initiation of bowel inflammatory lesions in CD may involve up-regulation of IL-12 production, resulting in conditions that maximally promote type 1 T-helper immune responses.
This article has been cited by other articles:
 |
|
 |
|
  J. Heidemann, C. Ruther, M. Kebschull, W. Domschke, M. Bruwer, S. Koch, T. Kucharzik, and C. Maaser Expression of IL-12-related molecules in human intestinal microvascular endothelial cells is regulated by TLR3 Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1315 - G1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Isomaki, T. Alanara, P. Isohanni, A. Lagerstedt, M. Korpela, T. Moilanen, T. Visakorpi, and O. Silvennoinen The expression of SOCS is altered in rheumatoid arthritis Rheumatology, October 1, 2007; 46(10): 1538 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. P. Singh, S. Singh, R. Singh, R. K. Karls, F. D. Quinn, M. E. Potter, and J. W. Lillard Jr. Influence of Mycobacterium avium subsp. paratuberculosis on Colitis Development and Specific Immune Responses during Disease Infect. Immun., August 1, 2007; 75(8): 3722 - 3728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dotan, M. Allez, A. Nakazawa, J. Brimnes, M. Schulder-Katz, and L. Mayer Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-{gamma} Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1630 - G1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Chen, P. Keshavan, G. D. Gregory, and D. J. Klumpp RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1372 - F1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wada, R. Lu, D. Zhou, J. Chu, T. Przewloka, S. Zhang, L. Li, Y. Wu, J. Qin, V. Balasubramanyam, et al. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor Blood, February 1, 2007; 109(3): 1156 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kullberg, D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J. Exp. Med., October 30, 2006; 203(11): 2485 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. BRAAT, M. P PEPPELENBOSCH, and D. W HOMMES Immunology of Crohn's disease. Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 135 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Bonder, S. R. Clark, M. U. Norman, P. Johnson, and P. Kubes Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere Blood, June 15, 2006; 107(12): 4798 - 4806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Yoshihara, T Yajima, C Kubo, and Y Yoshikai Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice Gut, March 1, 2006; 55(3): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Bonder, M. U. Norman, T. MacRae, P. R. Mangan, C. T. Weaver, D. C. Bullard, D.-M. McCafferty, and P. Kubes P-Selectin Can Support Both Th1 and Th2 Lymphocyte Rolling in the Intestinal Microvasculature Am. J. Pathol., December 1, 2005; 167(6): 1647 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M Coccia, M E Remoli, C Di Giacinto, B Del Zotto, E Giacomini, G Monteleone, and M Boirivant Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease Gut, November 1, 2005; 54(11): 1558 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kouroumalis, R. J. Nibbs, H. Aptel, K. L. Wright, G. Kolios, and S. G. Ward The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate G{alpha}i-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts J. Immunol., October 15, 2005; 175(8): 5403 - 5411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Kawashima, N Oshitani, Y Jinno, K Watanabe, S Nakamura, K Higuchi, and T Arakawa Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease J. Clin. Pathol., October 1, 2005; 58(10): 1057 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Melgar, A. Karlsson, and E. Michaelsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1328 - G1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Braat, J. van den Brande, E. van Tol, D. Hommes, M. Peppelenbosch, and S. van Deventer Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1618 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Mannon, I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al. Anti-Interleukin-12 Antibody for Active Crohn's Disease N. Engl. J. Med., November 11, 2004; 351(20): 2069 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Sturm, A Z A Leite, S Danese, K A Krivacic, G A West, S Mohr, J W Jacobberger, and C Fiocchi Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis Gut, November 1, 2004; 53(11): 1624 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Stallmach, T Marth, B Weiss, B M Wittig, A Hombach, C Schmidt, M Neurath, M Zeitz, S Zeuzem, and H Abken An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo Gut, March 1, 2004; 53(3): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ishida, T. Maegawa, T. Kondo, A. Kimura, Y. Iwakura, S. Nakamura, and N. Mukaida Essential Involvement of IFN-{gamma} in Clostridium difficile Toxin A-Induced Enteritis J. Immunol., March 1, 2004; 172(5): 3018 - 3025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Myles, R. S. Livingston, B. A. Livingston, J. M. Criley, and C. L. Franklin Analysis of Gene Expression in Ceca of Helicobacter hepaticus-Infected A/JCr Mice before and after Development of Typhlitis Infect. Immun., July 1, 2003; 71(7): 3885 - 3893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L.E. Ellingson, J. C. Cheville, D. Brees, J. M. Miller, and N. F. Cheville Absence of Mycobacterium avium subspecies paratuberculosis Components from Crohn's Disease Intestinal Biopsy Tissues Clin. Med. Res., July 1, 2003; 1(3): 217 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sasaki, T. Tsuji, T. Jinushi, J. Matsuzaki, T. Sato, K. Chamoto, Y. Togashi, T. Koda, and T. Nishimura Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets Int. Immunol., June 1, 2003; 15(6): 701 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Okuda, I. Takahashi, J.-K. Kim, N. Ohta, K. Iwatani, H. Iijima, Y. Kai, H. Tamagawa, T. Hiroi, M.-N. Kweon, et al. Development of Colitis in Signal Transducers and Activators of Transcription 6-Deficient T-Cell Receptor {alpha}-Deficient Mice: A Potential Role of Signal Transducers and Activators of Transcription 6-Independent Interleukin-4 Signaling for the Generation of Th2-Biased Pathological CD4+{beta}{beta}T Cells Am. J. Pathol., January 1, 2003; 162(1): 263 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. H. VAN DEN BRANDE, M. P. PEPPELENBOSCH, and S. J. H. VAN DEVENTER Treating Crohn's Disease by Inducing T Lymphocyte Apoptosis Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 166 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. VAN DEN BLINK, T. TEN HOVE, G. R. VAN DEN BRINK, M. P. PEPPELENBOSCH, and S. J.H. VAN DEVENTER From Extracellular to Intracellular Targets, Inhibiting MAP Kinases in Treatment of Crohn's Disease Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 349 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, M.-T. Ochoa, S. R. Krutzik, O. Takeuchi, S. Uematsu, A. J. Legaspi, H. D. Brightbill, D. Holland, W. J. Cunliffe, S. Akira, et al. Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses J. Immunol., August 1, 2002; 169(3): 1535 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Murata, A. Yamashita, T. Saito, K. Sugamura, and J. Hamuro The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3-/- and IL-2 receptor {gamma}-/- mice Int. Immunol., June 1, 2002; 14(6): 627 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Monteleone, P Vavassori, L Biancone, G Monteleone, and F Pallone Immunoregulation in the gut: success and failures in human disease Gut, May 1, 2002; 50(90003): iii60 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Iqbal, J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver T Helper 1 and T Helper 2 Cells Are Pathogenic in an Antigen-specific Model of Colitis J. Exp. Med., January 7, 2002; 195(1): 71 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Middel, K Reich, F Polzien, V Blaschke, B Hemmerlein, J Herms, M Korabiowska, and H-J Radzun Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease Gut, December 1, 2001; 49(6): 795 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Siegmund, G. Fantuzzi, F. Rieder, F. Gamboni-Robertson, H.-A. Lehr, G. Hartmann, C. A. Dinarello, S. Endres, and A. Eigler Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1264 - R1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakase, K. Okazaki, Y. Tabata, S. Uose, M. Ohana, K. Uchida, T. Nishi, A.'s Debreceni, T. Itoh, C. Kawanami, et al. An Oral Drug Delivery System Targeting Immune-Regulating Cells Ameliorates Mucosal Injury in Trinitrobenzene Sulfonic Acid-Induced Colitis J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1122 - 1128. [Abstract] [Full Text]
|
|
|
|
|
|
M. Boirivant, I. J. Fuss, L. Ferroni, M. De Pascale, and W. Strober Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis J. Immunol., March 1, 2001; 166(5): 3522 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Siegmund, F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G. S. Firestein, D. Boyle, H.-A. Lehr, F. Loher, G. Hartmann, et al. Adenosine Kinase Inhibitor GP515 Improves Experimental Colitis in Mice J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 99 - 105. [Abstract] [Full Text]
|
|
|
|
|
|
T. Parrello, G. Monteleone, S. Cucchiara, I. Monteleone, L. Sebkova, P. Doldo, F. Luzza, and F. Pallone Up-Regulation of the IL-12 Receptor {beta}2 Chain in Crohn's Disease J. Immunol., December 15, 2000; 165(12): 7234 - 7239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hallquist, A. Hakki, L. Wecker, H. Friedman, and S. Pross Differential Effects of Nicotine and Aging on Splenocyte Proliferation and the Production of Th1- Versus Th2-Type Cytokines Experimental Biology and Medicine, July 1, 2000; 224(3): 141 - 146. [Abstract] [Full Text]
|
|
|
|
|
|
T. Spieker and H. Herbst Distribution and Phenotype of Epstein-Barr Virus-Infected Cells in Inflammatory Bowel Disease Am. J. Pathol., July 1, 2000; 157(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Demetter, D Baeten, F De Keyser, M De Vos, N Van Damme, G Verbruggen, S Vermeulen, M Mareel, D Elewaut, H Mielants, et al. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex Ann Rheum Dis, March 1, 2000; 59(3): 211 - 216. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Liu, S. Colpaert, G. R. D'Haens, A. Kasran, M. d. Boer, P. Rutgeerts, K. Geboes, and J. L. Ceuppens Hyperexpression of CD40 Ligand (CD154) in Inflammatory Bowel Disease and Its Contribution to Pathogenic Cytokine Production J. Immunol., October 1, 1999; 163(7): 4049 - 4057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iijima, I. Takahashi, D. Kishi, J.-K. Kim, S. Kawano, M. Hori, and H. Kiyono Alteration of Interleukin 4 Production Results in the Inhibition of T Helper Type 2 Cell–dominated Inflammatory Bowel Disease in T Cell Receptor {alpha} Chain–deficient Mice J. Exp. Med., September 6, 1999; 190(5): 607 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iwasaki and B. L. Kelsall Freshly Isolated Peyer's Patch, But Not Spleen, Dendritic Cells Produce Interleukin 10 and Induce the Differentiation of T Helper Type 2 Cells J. Exp. Med., July 19, 1999; 190(2): 229 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Monteleone, F. Trapasso, T. Parrello, L. Biancone, A. Stella, R. Iuliano, F. Luzza, A. Fusco, and F. Pallone Bioactive IL-18 Expression Is Up-Regulated in Crohn's Disease J. Immunol., July 1, 1999; 163(1): 143 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Pizarro, M. H. Michie, M. Bentz, J. Woraratanadharm, M. F. Smith Jr., E. Foley, C. A. Moskaluk, S. J. Bickston, and F. Cominelli IL-18, a Novel Immunoregulatory Cytokine, Is Up-Regulated in Crohn's Disease: Expression and Localization in Intestinal Mucosal Cells J. Immunol., June 1, 1999; 162(11): 6829 - 6835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men" Toxicol Pathol, January 1, 1999; 27(1): 123 - 133. [Abstract] [PDF]
|
|
|
|
|
|
F PALLONE and G MONTELEONE Interleukin 12 and Th1 responses in inflammatory bowel disease Gut, December 1, 1998; 43(6): 735 - 736. [Full Text] [PDF]
|
|
|
|
|
|
M. Boirivant, I. J. Fuss, A. Chu, and W. Strober Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4 J. Exp. Med., November 16, 1998; 188(10): 1929 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Davidson, S. A. Hudak, R. E. Lesley, S. Menon, M. W. Leach, and D. M. Rennick IL-12, But Not IFN-{gamma}, Plays a Major Role in Sustaining the Chronic Phase of Colitis in IL-10-Deficient Mice J. Immunol., September 15, 1998; 161(6): 3143 - 3149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Scala, M. Carbonari, P. Del Porto, M. Cibati, T. Tedesco, A. M. Mazzone, R. Paganelli, and M. Fiorilli Lymphocyte Activation Gene-3 (LAG-3) Expression and IFN-{gamma} Production Are Variably Coregulated in Different Human T Lymphocyte Subpopulations J. Immunol., July 1, 1998; 161(1): 489 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Romagnani, F. Annunziato, R. Manetti, C. Mavilia, L. Lasagni, C. Manuelli, G. B. Vannelli, V. Vanini, E. Maggi, C. Pupilli, et al. High CD30 Ligand Expression by Epithelial Cells and Hassal's Corpuscles in the Medulla of Human Thymus Blood, May 1, 1998; 91(9): 3323 - 3332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Simpson, S. Shah, M. Comiskey, Y. P. de Jong, B. Wang, E. Mizoguchi, A. K. Bhan, and C. Terhorst T Cell-mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon gamma Expression by T Cells J. Exp. Med., April 20, 1998; 187(8): 1225 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. F. Pender, J. M. E. Fell, S. M. Chamow, A. Ashkenazi, and T. T. MacDonald A p55 TNF Receptor Immunoadhesin Prevents T Cell-Mediated Intestinal Injury by Inhibiting Matrix Metalloproteinase Production J. Immunol., April 15, 1998; 160(8): 4098 - 4103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. SCHLUGER and W. N. ROM The Host Immune Response to Tuberculosis Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 679 - 691. [Full Text] [PDF]
|
|
|
|
|
|
A. Mizoguchi, E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan Suppressive Role of B Cells in Chronic Colitis of T Cell Receptor alpha Mutant Mice J. Exp. Med., November 17, 1997; 186(10): 1749 - 1756. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
